This story first appeared in AI Prognosis newsletter, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. Over
Where is DeepMind’s AI protein design spinout? The Alphabet-owned AI company took the biology world by storm in 2020 with AlphaFold2, the protein structure prediction
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered
It was January 2023. Elon Musk owned Twitter, but it wasn’t yet called X. ChatGPT had been released barely six weeks earlier. Absci CEO Sean
Andrew Pierce is the senior vice president of discovery and development at a company that claims to be “first end-to-end AI biotech,” but he admits
A day after President Donald Trump rescinded Biden’s executive order urging federal agencies to formulate standards for responsible development of artificial intelligence, Maia Hightower, CEO
Artificial intelligence models are ever-hungry black boxes that need boatloads of bits and bytes from a wide stream of real-world data in order to produce
Health data company Truveta said Monday it’s partnering with health systems and drugmakers to launch the Truveta Genome Project, a database of genetic data that
In 2020, news headlines repeated John Moult’s words at the end of a stunning competition: Artificial intelligence had “solved” a long-standing grand challenge in biology,
State lawmakers are fed up with federal inaction on artificial intelligence and are taking matters into their own hands. Lawmakers in Colorado, California, and Connecticut